Source: Citybizlist

British Business Bank: Draig Therapeutics Closes $65M Series B Led by Deep Track Capital

Draig Therapeutics, a clinical-stage biopharmaceutical company developing neuropsychiatric therapies, has announced the closing of an oversubscribed $65 million Series B... Read More The post Draig Therapeutics Closes $65M Series B Led by Deep Track Capital appeared first on citybiz.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Louis Taylor's photo - CEO of British Business Bank

CEO

Louis Taylor

CEO Approval Rating

82/100

Read more